Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

KRX-0401 Perifosine

KRX-0401 is undergoing clinical trials for its use as treatment for multiple myeloma and multiple other forms of cancer. It has been awarded a fast track designation and orphan drug status by the FDA.



Go Top